Physician profile
Igor Ilyabayev
NPI 1013188242
$1,723.80
in general payments reported to CMS, 2019-2025
11 companies · $650 in 2025
The $650 reported for 2025 was more than what 92% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.30 · 2020: $56.96 · 2022: $200 · 2023: $99.41 · 2024: $673 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735 · Gift: $563 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.84 |
| Gift | $562.70 |
| Education | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $554.00 | 2024-2025 | |
| Align Technology, INC. | $514.18 | 2024-2025 | Invisalign |
| Midmark Corporation | $200.00 | 2022 | |
| Neurocrine Biosciences, INC. | $172.65 | 2024 | Ingrezza |
| Peter Brasseler Holdings, LLC | $85.74 | 2019-2020 | |
| Nobel Biocare USA | $79.21 | 2023 | Nobelactive |
| Dentsply Sirona INC | $31.10 | 2020-2025 | Cavitron |
| Voco America INC. | $30.60 | 2023-2025 | Meron Plus Qm, Futurabond U, Admira Fusion |
| Orapharma, A Division of Bausch Health US, LLC | $20.99 | 2024 | Arestin |
| Straumann USA LLC | $19.37 | 2025 | |
| Philips North America LLC | $15.96 | 2025 | Oral Health Care Undivided |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Ilyabayev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.